Beta-o2 Technologies Ltd.

Beta-o2 Technologies Ltd. is at the forefront of biotechnology research, dedicated to developing innovative solutions for critical health challenges. Located at 11 Amal St., P.O.B 11793, Rosh Ha'ain, 4809900, IL, Beta-o2 Technologies Ltd. is focused on creating the ßAir Bio-artificial Pancreas, an advanced therapeutic approach intended to provide a functional cure for Type 1 diabetes (T1D). The company's pioneering work addresses the unmet needs of patients with T1D, who are unable to produce insulin, by providing a safe and effective environment for insulin-producing beta cells to thrive and function on demand.

Beta-o2 Technologies Ltd. has made significant strides in overcoming the major challenges associated with islet transplantation. Their groundbreaking approach creates a protective environment that supports the long-term survival and functionality of transplanted cells without the need for life-long immunosuppression drugs. This innovative technology ensures that the cells remain alive and continue to function effectively within the recipient's body, providing a sustainable source of insulin.

With a commitment to improving the lives of individuals affected by Type 1 diabetes, Beta-o2 Technologies Ltd. continues to advance its research and development efforts. The company's dedication to scientific excellence and patient-centric solutions positions Beta-o2 Technologies Ltd. as a key player in the biotechnology industry. We invite the manager of Beta-o2 Technologies Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovations.